Alternative Medicine: It's Time to Get Smart

Doctors and their patients often hold different ideas about disease and how to treat it. When it comes to alternative medicine, the line seems clear. The public prefers alternative treatments--acupuncture, herbal remedies, imagery, therapeutic touch--to the drugs, psychotherapies, and surgery offered by the medical establishment. According to a 1993 report in the New England Journal of Medicine (D.M. Eisenberg et al., 328:246-52) Americans make more visits to alternative healers and spend more

Written byWalter Brown
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Doctors and their patients often hold different ideas about disease and how to treat it. When it comes to alternative medicine, the line seems clear. The public prefers alternative treatments--acupuncture, herbal remedies, imagery, therapeutic touch--to the drugs, psychotherapies, and surgery offered by the medical establishment. According to a 1993 report in the New England Journal of Medicine (D.M. Eisenberg et al., 328:246-52) Americans make more visits to alternative healers and spend more money on alternative treatments than they do on conventional medicine. But physicians are skeptical about the value of such therapies and not infrequently hostile to them. The skepticism is well founded.

Few alternative therapies have been subjected to scientific scrutiny, and many of them--touch therapy and homeopathy come to mind--are based on theories that are, at best, unconvincing. Nonetheless, practitioners of alternative medicine and their clients are convinced that these treatments work. U.S. Rep. Peter DeFazio (D-Ore.), an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies